Hospital-acquired Clostridium difficile infection: Determinants for severe disease

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1923-1930

  Wenisch, J M ^a   Schmid, D ^b   Kuo, H W ^b   Simons, E ^b   Allerberger, F ^b,c   Michl, V ^d   Tesik, P ^d   Tucek, G ^d   Wenisch, C ^d,e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

^d KAISER FRANZ JOSEF HOSPITAL   (Austria)

^e 4Medizinische Abteilung Mit Infektions und Tropenmedizin   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; CROSS-SECTIONAL STUDY; DEHYDRATION; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; FEMALE; HOSPITAL ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; TOXIC MEGACOLON;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DIARRHEA; FEMALE; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84866356015     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1522-5     Document Type: Article

References (44)

1. Lyytikainen O, Turunen H, Sund R, Rasinpera M, Kononen E, Ruutu P, Keskimaki I (2009) Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004. Emerg Infect Dis 15(5):761-765
2. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F (2009) Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. Euro Surveill 14(17
3. Indra A, Huhulescu S, Hasenberger P, Schmid D, Alfery C, Wuerzner R, Fille M, Gattringer K, Kuijper E, Allerberger F (2006) First isolation of Clostridium difficile PCR ribotype 027 in Austria. Euro Surveill 11(9
4. Zilberberg MD (2009) Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis 15(1):122-124
5. Zilberberg MD, Shorr AF, Kollef MH (2008) Increase in adult Clostridium difficile -related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 14(6):929-931 (Pubitemid 351838602)
6. Zilberberg MD, Shorr AF, Micek ST, Doherty JA, Kollef MH (2009) Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med 37(9):2583-2589
7. Vaishnavi C, Bhasin D, Kochhar R, Singh K (2000) Clostridium difficile toxin and faecal lactoferrin assays in adult patients. Microbes Infect 2(15):1827-1830 (Pubitemid 32063535)
8. Vaishnavi C, Thapa BR, Thennarasu K, Singh K (2002) Faecal lactoferrin assay as an adjunct to Clostridium difficile diarrhoea. Indian J Pathol Microbiol 45(1):69-73
9. Kyne L, Warny M, Qamar A, Kelly CP (2001) Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357(9251):189-193 (Pubitemid 32108091)
10. Sharma AK, Holder FE (1998) Clostridium difficile diarrhea after use of tacrolimus following renal transplantation. Clin Infect Dis 27(6):1540-1541 (Pubitemid 29242443)
11. Cunningham R, Dale B, Undy B, Gaunt N (2003) Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 54(3):243-245 (Pubitemid 38002001)
12. Pepin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41(9):1254-1260 (Pubitemid 41532667)
13. Vaishnavi C (2009) Established and potential risk factors for Clostridum difficile infection. Indian J Med Microbiol 27(4):289-300
14. Eddi R, Malik MN, Shakov R, Baddoura WJ, Chandran C, Debari VA (2010) Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology 15(4):471-475
15. Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM (2007) Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 64(22):2359- 2363 (Pubitemid 350174708)
16. Jayatilaka S, Shakov R, Eddi R, Bakaj G, Baddoura WJ, DeBari VA (2007) Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors. Ann Clin Lab Sci 37(3):241-247 (Pubitemid 47311340)
17. Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294(23):2989-2995 (Pubitemid 41817660)
18. Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN (2006) Proton pump inhibitors and hospitalization for Clostridium difficile- associated disease: a population-based study. Clin Infect Dis 43(10):1272-1276 (Pubitemid 44706452)
19. Hookman P, Barkin JS (2009) Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 15(13):1554-1580
20. Andrews CN, Raboud J, Kassen BO et al (2003) Clostridium difficile- associated diarrhea: predictors of severity in patients presenting to the emergency department. Can J Gastroenterol 17:369-373 (Pubitemid 36958164)
21. Kenneally C, Rosini JM, Skrupky LP, Doherty JA, Hollands JM, Martinez E, McKinzie WE, Murphy T, Smith JR, Micek ST, Kollef MH (2007) Analysis of 30-day mortality for Clostridium difficileassociated disease in the ICU setting. Chest 132:418-424 (Pubitemid 47282371)
22. Weiss B, Kleinkauf N, Eckmanns T, an der Heiden M, Neumann M, Michels H, Jansen A (2009) Risk factors related to a hospitalassociated cluster of Clostridium difficile PCR ribotype 027 infections in Germany During 2007. Infect Control Hosp Epidemiol 30 (3):282-284
23. Bauer MP, Kuijper EJ, van Dissel JT (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 15(12):1067-1079
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383 (Pubitemid 17055592)
25. Hell M, Permoser M, Chmelizek G, Kern JM, Maass M, Huhulescu S, Indra A, Allerberger F (2011) Clostridium difficile infection: monoclonal or polyclonal genesis? Infection 39(5):461-465
26. Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, Wewalka G, Allerberger F, Kuijper EJ (2008) Characterization of Clostridium difficile isolates by capillary gel electrophoresis based PCR ribotyping. J Med Microbiol 57:1377-1382
27. Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T (2009) Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents 33 (Suppl 1):S19-S23
28. Hubert B, Loo VG, Bourgault AM, Poirier L, Dascal A, Fortin E, Dionne M, Lorange M (2007) A portrait of the geographic dissemination of the Clostridium difficile North American pulsedfield type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 44(2):238-244 (Pubitemid 46079988)
29. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353(23):2442-2449 (Pubitemid 41770165)
30. Barbut F, Decre D, Lalande V, Burghoffer B, Noussair L, Gigandon A, Espinasse F, Raskine L, Robert J, Mangeol A, Branger C, Petit JC (2005) Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 54(Pt 2):181-185 (Pubitemid 40868005)
31. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S, Thompson A, Jensen B, Wiggs L, Bessette J, Martin J, Clukey J, Gensheimer K, Killgore G, McDonald LC (2006) A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 166(22):2518- 2524 (Pubitemid 44913237)
32. Morgan OW, Rodrigues B, Elston T, Verlander NQ, Brown DF, Brazier J, Reacher M (2008) Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 3(3): e1812
33. McGowan AP, Lalayiannis LC, Sarma JB, Marshall B, Martin KE, Welfare MR (2011) Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. J Hosp Infect 77(1):11-15
34. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobialresistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136(11):834-844 (Pubitemid 34568654)
35. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122 (1):262-268 (Pubitemid 34754172)
36. Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13(11):1048-1057 (Pubitemid 47553515)
37. Indra A, Schmid D, Huhulescu S, HellM, Gattringer R, Hasenberger P, Fiedler A, Wewalka G, Allerberger F (2008) Characterization of clinical Clostridiumdifficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007. JMed Microbiol 57(Pt 6):702- 708 (Pubitemid 351842061)
38. Barbut F, Petit JC (2001) Epidemiology of Clostridium difficileassociated infections. Clin Microbiol Infect 7(8):405-410
39. Gujja D, Friedenberg FK (2009) Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 29(6):635-642
40. Makris D, Desrousseaux B, Zakynthinos E, Durocher A, Nseir S (2011) The impact of COPD on ICU mortality in patients with ventilator-associated pneumonia. Respir Med 105(7):1022-1029
41. Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2011) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis. Sep 7 [Epub ahead of print]
42. Wang HE, Gamboa C, Warnock DG, Muntner P (2011) Chronic kidney disease and risk of death from infection. Am J Nephrol 34 (4):330-336
43. Shah BR, Hux JE (2003) Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 26(2):510-513 (Pubitemid 36929083)
44. Anonymous (2011) Vorläufiger Jahresausweis über meldepflichtige Infektionskrankheiten, Stand 05.10.11, Bundesministerium für Gesundheit. Available online: http://www.bmg.gv.at/home/ Schwerpunkte/Krankheiten/ Uebertragbare-Krankheiten/. Accessed 19 December 2011